Cargando…
Inhalable antibodies for the treatment of COVID-19
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509015/ https://www.ncbi.nlm.nih.gov/pubmed/36186549 http://dx.doi.org/10.1016/j.xinn.2022.100328 |
| _version_ | 1784797142881140736 |
|---|---|
| author | Yang, Zhenlin Li, Cheng Song, Yuanlin Ying, Tianlei Wu, Yanling |
| author_facet | Yang, Zhenlin Li, Cheng Song, Yuanlin Ying, Tianlei Wu, Yanling |
| author_sort | Yang, Zhenlin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9509015 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95090152022-09-26 Inhalable antibodies for the treatment of COVID-19 Yang, Zhenlin Li, Cheng Song, Yuanlin Ying, Tianlei Wu, Yanling Innovation (Camb) Commentary Elsevier 2022-09-24 /pmc/articles/PMC9509015/ /pubmed/36186549 http://dx.doi.org/10.1016/j.xinn.2022.100328 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Commentary Yang, Zhenlin Li, Cheng Song, Yuanlin Ying, Tianlei Wu, Yanling Inhalable antibodies for the treatment of COVID-19 |
| title | Inhalable antibodies for the treatment of COVID-19 |
| title_full | Inhalable antibodies for the treatment of COVID-19 |
| title_fullStr | Inhalable antibodies for the treatment of COVID-19 |
| title_full_unstemmed | Inhalable antibodies for the treatment of COVID-19 |
| title_short | Inhalable antibodies for the treatment of COVID-19 |
| title_sort | inhalable antibodies for the treatment of covid-19 |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509015/ https://www.ncbi.nlm.nih.gov/pubmed/36186549 http://dx.doi.org/10.1016/j.xinn.2022.100328 |
| work_keys_str_mv | AT yangzhenlin inhalableantibodiesforthetreatmentofcovid19 AT licheng inhalableantibodiesforthetreatmentofcovid19 AT songyuanlin inhalableantibodiesforthetreatmentofcovid19 AT yingtianlei inhalableantibodiesforthetreatmentofcovid19 AT wuyanling inhalableantibodiesforthetreatmentofcovid19 |